Lataa...
Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration
The discovery of numerous potent and broad neutralizing antibodies (bNAbs) against Human Immunodeficiency Virus type 1 (HIV-1) envelope glycoprotein has invigorated the potential of using them as an effective preventative and therapeutic agent. The majority of the anti-HIV-1 antibodies, currently un...
Tallennettuna:
| Julkaisussa: | Antibodies (Basel) |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7551838/ https://ncbi.nlm.nih.gov/pubmed/32751063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib9030036 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|